Disease progression in vascular cognitive impairment: Cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study

Journal of the Neurological Sciences

Volumn 252, Issue 2, 2007, Pages 106-112

  Rockwood, Kenneth ^a   King Moorhouse, Paige ^a   Song, Xiaowei ^a   MacKnight, Chris ^a   Gauthier, Serge ^b   Kertesz, Andrew ^c   Montgomery, Patrick ^d   Black, Sandra ^e   Hogan, D B ^f   Guzman, Antonio ^g   Bouchard, Rémi ^h   Feldman, Howard ⁱ  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h UNIVERSITÉ LAVAL   (Canada)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Disease progression; Executive dysfunction; Vascular cognitive impairment

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CANADA; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL OBSERVATION; COGNITIVE DEFECT; COHORT ANALYSIS; CONSORTIUM TO INVESTIGATE VASCULAR IMPAIRMENT OF COGNITION; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; VASCULAR COGNITIVE IMPAIRMENT;

AGED; AGED, 80 AND OVER; AGGRESSION; ALZHEIMER DISEASE; COGNITION; COGNITION DISORDERS; COHORT STUDIES; DELUSIONS; DEMENTIA, VASCULAR; DEPRESSION; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HALLUCINATIONS; HUMANS; INCIDENCE; MIDDLE AGED;

EID: 33845985940     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.10.015     Document Type: Article

References (60)

1. Gorelick P.B., and William M. Feinberg lecture: cognitive vitality and the role of stroke and cardiovascular disease risk factors. Stroke 36 (2005) 875-879
2. Bowler J.V. Vascular cognitive impairment. J Neurol Neurosurg Psychiatry 76 Suppl 5 (2005) v35-v44
3. Pantoni L., Sarti C., Alafuzoff I., Jellinger K., Munoz D.G., Ogata J., et al. Postmortem examination of vascular lesions in cognitive impairment: a survey among neuropathological services. Stroke 37 (2006) 1005-1009
4. Hachinski V. Vascular dementia: a radical redefinition. Dementia 5 (1994) 130-132
5. Rockwood K., Bowler J., Erkinjuntti T., Hachinski V., and Wallin A. Subtypes of vascular dementia. Alzheimer Dis Assoc Disord 13 Suppl 3 (1999) S59-S65
6. Rockwood K., Davis H., MacKnight C., Vandorpe R., Gauthier S., Guzman A., et al. The Consortium to Investigate Vascular Impairment of Cognition: methods and first findings. Can J Neurol Sci 30 (2003) 237-243
7. Rockwood K., Black S.E., Song X., Hogan D.B., Gauthier S., MacKnight C., et al. Clinical and radiographic subtypes of vascular cognitive impairment in a clinic- based cohort study. J Neurol Sci 240 1-2 (2006) 7-14
8. Erkinjuntti T., Roman G., Gauthier S., Feldman H., and Rockwood K. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 35 4 (2004) 1010-1017
9. Desmond D.W. The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit?. J Neurol Sci 226 (2004) 3-7
10. Craig D., and Birks J. Galantamine for vascular cognitive impairment. Cochrane Database Syst Rev 1 (2006) (CD004746)
11. Craig D., and Birks J. Rivastigmine for vascular cognitive impairment. Cochrane 2 (2005) (CD004744)
12. Malouf R., and Birks J. Donepezil for vascular cognitive impairment. Cochrane Database Syst Rev 1 (2004) (CD004395)
13. Schmidtke K., and Hull M. Cerebral small vessel disease: how does it progress?. J Neurol Sci 229-230 (2005) 13-20
14. McShane R., Areosa Sastre A., and Minakaran N. Memantine for dementia. Cochrane Database Syst Rev 2 (2006) (CD003154)
15. Leblanc G.G., Meschia J.F., Stuss D.T., and Hachinski V. Genetics of vascular cognitive impairment: the opportunity and the challenges. Stroke 37 1 (2006) 248-255
16. O'Brien J.T., Erkinjuntti T., Reisberg B., Roman G., Sawada T., Pantoni L., et al. Vascular cognitive impairment. Lancet Neurol 2 2 (2003) 89-98
17. Roman G.C., Sachdev P., Royall D.R., Bullock R.A., Orgogozo J.M., Lopez-Pousa S., et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 226 1-2 (2004) 81-87
18. Ingles J.L., Wentzel C., Fisk J.D., and Rockwood K. Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia. Stroke 33 8 (2002) 1999-2002
19. Rockwood K., Wentzel C., Hachinski V., Hogan D.B., MacKnight C., and McDowell I. Prevalence and outcomes of vascular cognitive impairment. Vascular cognitive impairment investigators of the Canadian study on health and aging. Neurology 54 (2000) 447-451
20. Galluzzi S., Sheu C.F., Zanetti O., and Frisoni G.B. Distinctive clinical features of mild cognitive impairment with subcortical cerebrovascular disease. Dement Geriatr 19 4 (2005) 196-203
21. Sachdev P.S., Brodaty H., Valenzuela M.J., Lorentz L., Looi J.C., Berman K., et al. Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney stroke study. Dement Geriatr Cogn Disord 21 5-6 (2006) 275-283
22. Ballard C., O'Brien J., Morris C.M., Barber R., Swann A., Neill D., et al. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry 16 (2001) 499-503
23. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
24. American Psychiatric Association. Diagnostic and Statistical manual. 3rd ed., revised (1987), APA, Washington, D.C.
25. Hachinski V.C., Iliff L.D., Zilhka E., Du Boulay G.H., McAllister V.L., Marshall J., et al. Cerebral blood flow in dementia. Arch Neurol 32 (1975) 632-637
26. Román G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 43 (1993) 650-660
27. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., and Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 42 (1992) 473-480
28. World Health Organization International Classification of Diseases. The ICD-10 Classification of Mental and Behavioural Disorders: clinical descriptors and diagnostic guidelines. 10th ed. (1992), WHO, Geneva
29. Gélinas I., Gauthier L., McIntyre M., and Gauthier S. Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther 53 (1999) 471-481
30. Folstein M.F., Folstein S.E., and McHugh P.R. The Folstein Mini-Mental State Examination: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
31. Reisberg B. Functional Assessment Staging (FAST). Psychopharmacol Bull 24 (1988) 653-659
32. Reisberg B., Ferris S.H., de Leon M.J., and Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 139 9 (1982) 1136-1139
33. Feldman H., Schulzer M., Wang S., Tuokko H., and Beattie B.L. The Functional Rating Scale in Alzheimer's disease assessment: a longitudinal study. In: Iqbal K., Mortimer J.A., Winblad B., and Wisniewski H.M. (Eds). Research Advances in Alzheimer's Disease and Related Disorders Chichester (1995), Wiley, UK 235-241
34. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43 11 (Nov 1993) 2412-2414
35. Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., Adey M.B., et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiat Res 17 (1983) 37-49
36. Conwell Y., Forbes N.T., Cox C., and Caine E.D. Validation of a measure of physical illness burden at autopsy: the Cumulative Illness Rating Scale. J Am Geriatr Soc 41 (1993) 38-41
37. In: Rockwood K., McDowell I., and Wolfson C. (Eds). Canadian Study of Health and Aging. Technical papers. Int Psychogeriatr vol. 13 (2001) 1-237 Suppl1
38. Feldman H., Levy A.R., Hsiung G.Y., Peters K.R., Donald A., Black S.E., et al. A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology 22 (2003) 265-274
39. Wentzel C., Darvesh S., MacKnight C., Shea C., and Rockwood K. Inter-rater reliability of the diagnosis of vascular cognitive impairment at a memory clinic. Neuroepidemiology 19 (2000) 186-193
40. Jorm A.F. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med 24 (1994) 145-153
41. Stewart M., McDowell I., Hill G., and Aylesworth R. Estimating antemortem cognitive status of deceased subjects in a longitudinal study of dementia. Int Psychogeriatr 13 Supp1 (2001) 99-106
42. Ebly E.M., Hogan D.B., and Parhad I.M. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol 52 (1995) 612-619
43. Cohen J. Statistical power analysis of the behavioural sciences. 2nd Ed. New York (1988)
44. Roman G.C., Wilkinson D.G., Doody R.S., Black S.E., Salloway S.P., and Schindler R.J. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials. Dement Geriatr Cogn Disord 20 (2005) 338-344
45. Pantoni L. Treatment of vascular dementia: evidence from trials with non-cholinergic drugs. J Neurol Sci 226 1-2 (2004) 67-70
46. Lind K., Edman A., Karlsson I., Sjogren M., and Wallin A. Relationship between depressive symptomatology and the subcortical brain syndrome in dementia. Int J Geriatr Psychiatry 17 (2002) 774-778
47. Frisoni G.B., Galluzzi S., Bresciani L., Zanetti O., and Geroldi C. Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome. J Neurol 249 10 (2002) 1423-1432
48. Sachdev P.S., Brodaty H., Valenzuela M.J., Lorentz L., Looi J.C., Wen W., et al. The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology 62 6 (2004) 912-919
49. Garrett K.D., Browndyke J.N., Whelihan W., Paul R.H., DiCarlo M., Moser D.J., et al. The neuropsychological profile of vascular cognitive impairment-no dementia: comparisons to patients at risk for cerebrovascular disease and vascular dementia. Arch Clin Neuropsychol 19 (2004) 745-757
50. Nyenhuis D.L., Gorelick P.B., Geenen E.J., Smith C.A., Gencheva E., Freels S., et al. The pattern of neuropsychological deficits in Vascular Cognitive Impairment-No Dementia (Vascular CIND). Clin Neuropsychol 18 (2004) 41-49
51. Nordahl C.W., Ranganath C., Yonelinas A.P., DeCarli C., Reed B.R., and Jagust W.J. Different mechanisms of episodic memory failure in mild cognitive impairment. Neuropsychologia 43 (2005) 1688-1697
52. Graham N.L., Emery T., and Hodges J.R. Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry 75 (2004) 61-71
53. Royall D.R., Palmer R., Chiodo L.K., and Polk M.J. Executive control mediates memory's association with change in instrumental activities of daily living: the Freedom House Study. J Am Geriatr Soc 53 (2005) 11-17
54. Voss S.E., and Bullock R.A. Executive function: the core feature of dementia?. Dement Geriatr Cogn Disord 18 (2004) 207-216
55. Alexopoulos G.S., Meyers B.S., Young R.C., Campbell S., Silbersweig D., and Charlson M. Vascular depression' hypothesis. Arch Gen Psychiatry 54 (1997) 915-922
56. Alexopoulos G.S. "The depression-executive dysfunction syndrome of late life": a specific target for D3 agonists?. Am J Geriatr Psychiatry 9 (2001) 22-29
57. Song X., Mitnitski A., and Rockwood K. Index variables for studying outcomes in vascular cognitive impairment. Neuroepidemiology 25 (2005) 196-204
58. King P., Song X., and Rockwood K. Cognitive impairment of acute onset in the consortium to investigate vascular impairment of cognition (CIVIC) study: Occurrence, correlates and outcomes. Am J Geriatr Psychiatry 14 (2006) 893-896
59. Langa K.M., Foster N.L., and Larson E.B. Mixed dementia: emerging concepts and therapeutic implications. JAMA 292 (2004) 2901-2908
60. O'Brien J.T. Vascular cognitive impairment. Am J Geriatr Psychiatry 14 (2006) 724-733